Related Experiment Video
Updated: Feb 10, 2026

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
RAS and sex differences in diabetic nephropathy
Sergi Clotet1, Marta Riera1, Julio Pascual1
1Hospital del Mar-IMIM.
Abstract:
The incidence and progression of kidney diseases are influenced by sex. The renin-angiotensin system (RAS) is an important regulator of cardiovascular and renal function. Sex differences in the renal response to RAS blockade have been demonstrated. Circulating and renal RAS has been shown to be altered in type 1 and type 2 diabetes; this enzymatic cascade plays a critical role in the development of diabetic nephropathy (DN). Angiotensin converting enzyme (ACE) and ACE2 are differentially regulated depending on its localization within the diabetic kidney. Furthermore, clinical and experimental studies have shown that circulating levels of sex hormones are clearly modulated in the context of diabetes, suggesting that sex-dependent RAS regulation may be also be affected in these individuals. The effect of sex hormones on circulating and renal RAS may be involved in the sex differences observed in DN progression. In this paper we will review the influence of sex hormones on RAS expression and its relation to diabetic kidney disease. A better understanding of the sex dimorphism on RAS might provide a new approach for diabetic kidney disease treatment.
Insights
Sex hormones influence the renin-angiotensin system (RAS), impacting kidney disease progression in diabetes. Understanding these sex differences in RAS may lead to new diabetic kidney disease treatments.
Area of Science:
- Nephrology
- Endocrinology
- Cardiovascular Science
Background:
- Sex influences kidney disease incidence and progression.
- The renin-angiotensin system (RAS) regulates cardiovascular and renal function.
- Sex differences exist in renal responses to RAS blockade.
Purpose of the Study:
- To review the influence of sex hormones on RAS expression.
- To explore the relationship between sex hormones, RAS, and diabetic kidney disease (DN).
- To highlight potential new therapeutic approaches for DN based on sex dimorphism in RAS.
Main Methods:
- Literature review of clinical and experimental studies.
- Analysis of sex hormone modulation in diabetes.
- Examination of RAS alterations in the diabetic kidney.
Main Results:
- RAS is altered in type 1 and type 2 diabetes, playing a role in DN.
- Angiotensin-converting enzyme (ACE) and ACE2 are differentially regulated in the diabetic kidney.
- Sex hormones modulate circulating and renal RAS, potentially explaining sex differences in DN progression.
Conclusions:
- Sex hormone effects on RAS are implicated in sex-dependent DN progression.
- Understanding sex dimorphism in RAS offers novel therapeutic strategies for diabetic kidney disease.
Related Concept Videos
Sex-linked Disorders
The Ras Gene
Ras is a...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Electric Potential and Potential Difference
When a test charge moves from the initial to the final position, the electric potential difference between those positions is defined as the ratio of the change in the potential energy to the charge on the...
Difference from Background: Limit of Detection
The LOD indicates the presence or absence...

